Clinical Trials Browser

Phase 2 × Lymphoma, Large B-Cell, Diffuse × Everolimus × Clear all

NCT04305444 2025-01-08

Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Leukemia, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00978432 2016-11-25

Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Phase 2 Terminated

50 enrolled 11 charts

Lymphoid

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT00869999 2014-10-27

Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

Phase 2 Completed

26 enrolled 8 charts

Lymphoid

Lymphoma, Large B-Cell, Diffuse